Tishcon Corp.
Westbury, NY, United States
Due-diligence reportFind an accredited testing lab and confirm its scope covers your product and methods.
Tishcon Corp. is a dietary supplement manufacturer in Westbury, NY, United States, certified to NSF/ANSI 455-2 GMP, with 7 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, powders, softgels and tablets.
- Website
- tishcon.com
- Phone
- 516-333-3050
- Facilities listed
- 10
- Last checked
Dosage forms
As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.
Certified facilities
818 Brown Street, Salisbury, MD 21804, United States
Manufacturing- Coating
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Quality Unit Operations
- Tablet Compression
- Warehousing
41 New York Avenue, Westbury, NY 11590, United States
Manufacturing- Quality Unit Operations
36 New York Avenue, Westbury, NY 11590, United States
Manufacturing- Encapsulation
- Liquid Formulation
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Quality Unit Operations
30 New York Avenue, Westbury, NY 11590, United States
Manufacturing- Encapsulation
- Liquid Formulation
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Quality Unit Operations
2410 N. Zion Road, Salisbury, MD 21801, United States
Manufacturing- Dry Formulation
- Encapsulation
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Packaging/Labeling Operation - Primary Packaging
- Packaging/Labeling Operation - Secondary Packaging
- Quality Unit Operations
- Tablet Compression
- Warehousing
28 New York Avenue, Westbury, NY 11590, United States
Manufacturing- Warehousing
Show all 10 facilities, grouped by type
Manufacturing (7)
818 Brown Street, Salisbury, MD 21804, United States
- Coating
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Quality Unit Operations
- Tablet Compression
- Warehousing
41 New York Avenue, Westbury, NY 11590, United States
- Quality Unit Operations
36 New York Avenue, Westbury, NY 11590, United States
- Encapsulation
- Liquid Formulation
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Quality Unit Operations
30 New York Avenue, Westbury, NY 11590, United States
- Encapsulation
- Liquid Formulation
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Quality Unit Operations
2410 N. Zion Road, Salisbury, MD 21801, United States
- Dry Formulation
- Encapsulation
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Packaging/Labeling Operation - Primary Packaging
- Packaging/Labeling Operation - Secondary Packaging
- Quality Unit Operations
- Tablet Compression
- Warehousing
28 New York Avenue, Westbury, NY 11590, United States
- Warehousing
17 Brooklyn Avenue, Westbury, NY 11590, United States
- Warehousing
Distribution (3)
28 New York Avenue, Westbury, NY 11590, United States
- Warehousing
608 Main Street, Westbury, NY 11590, United States
- Warehousing
17 Brooklyn Avenue, Westbury, NY 11590, United States
- Warehousing
How Tishcon Corp. compares
Among the 769 manufacturers we list, as of our last check.
- One of 21 capsule manufacturers we list in New York, and 325 in the United States. All capsule manufacturers in the USA · All in New York
- One of 24 tablet manufacturers we list in New York, and 228 in the United States. All tablet manufacturers in the USA · All in New York
- One of 12 softgel manufacturers we list in New York, and 160 in the United States. All softgel manufacturers in the USA · All in New York
- Has 7 listed manufacturing or packaging facilities; 99% of the manufacturers we list have fewer.
- Lists 4 dosage forms; 63% of the manufacturers we list have fewer.
FDA recall records
No food or dietary supplement recall found under the name Tishcon Corp. in FDA’s enforcement reports, as of .
We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check
FDA inspections
FDA lists 12 food or dietary supplement inspections at facilities matching Tishcon Corp., from 2009 to 2025, as of . 5 found no objectionable conditions and 7 found conditions the firm was left to correct.
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Salisbury, Maryland
7 citations posted:
- Physical plant - clean and sanitary (21 CFR 111.15(b))
- Equipment - design - appropriate and suitable (21 CFR 111.27(a))
- Specifications - components (21 CFR 111.70(b))
- Specifications - finished dietary supplement (21 CFR 111.70(e))
See all 7 citations
Physical plant - clean and sanitary (21 CFR 111.15(b))
You did not maintain your physical plant in a clean and sanitary condition.
Equipment - design - appropriate and suitable (21 CFR 111.27(a))
You did not use equipment or utensils suitable for its intended use.
Specifications - components (21 CFR 111.70(b))
For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications.
Specifications - finished dietary supplement (21 CFR 111.70(e))
You did not establish product specifications for identity, purity and strength.
Batch record - required information (21 CFR 111.260)
Your batch production record did not include all required information.
Conditions, controls -protect; microorganisms, contamination (21 CFR 111.365(a))
You did not perform manufacturing operations under conditions and controls that protect against the potential for contamination.
Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))
You held dietary supplements under conditions that lead to mix-up, contamination, or deterioration.
FEI 1122227
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Westbury, New York
5 citations posted:
- Specifications - components (21 CFR 111.70(b))
- Specifications - finished dietary supplement (21 CFR 111.70(e))
- Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
- Hold - temperature, humidity, light (21 CFR 111.455(a))
See all 5 citations
Specifications - components (21 CFR 111.70(b))
For component(s) used in the manufacture of a dietary supplement, you did not establish necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met.
Specifications - finished dietary supplement (21 CFR 111.70(e))
You did not establish product specifications for identity, purity, strength and composition.
Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.
Hold - temperature, humidity, light (21 CFR 111.455(a))
You did not hold dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.
Product complaint - review, investigation (21 CFR 111.560(c))
Your review and investigation of a product complaint did not extend to all relevant batches and records.
FEI 2431390
No action indicated · No objectionable conditions found
Inspected
Salisbury, Maryland
FEI 1122227
No action indicated · No objectionable conditions found
Inspected
Westbury, New York
FEI 2431390
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Salisbury, Maryland
3 citations posted:
- Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
- Components - contamination, deterioration, mix-ups (21 CFR 111.155(e))
- Batch record - specifications (21 CFR 111.260(i))
Full citation text
Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
Your quality control personnel did not approve or reject deviations or modifications that may affect the identity, purity, strength, or composition of a dietary supplement.
Components - contamination, deterioration, mix-ups (21 CFR 111.155(e))
You did not hold components under conditions that will protect against contamination.
Batch record - specifications (21 CFR 111.260(i))
Your batch production records did not include documentation that the finished dietary supplement meets established specifications.
FEI 1122227
Show all 12 inspections
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Salisbury, Maryland
7 citations posted:
- Physical plant - clean and sanitary (21 CFR 111.15(b))
- Equipment - design - appropriate and suitable (21 CFR 111.27(a))
- Specifications - components (21 CFR 111.70(b))
- Specifications - finished dietary supplement (21 CFR 111.70(e))
See all 7 citations
Physical plant - clean and sanitary (21 CFR 111.15(b))
You did not maintain your physical plant in a clean and sanitary condition.
Equipment - design - appropriate and suitable (21 CFR 111.27(a))
You did not use equipment or utensils suitable for its intended use.
Specifications - components (21 CFR 111.70(b))
For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications.
Specifications - finished dietary supplement (21 CFR 111.70(e))
You did not establish product specifications for identity, purity and strength.
Batch record - required information (21 CFR 111.260)
Your batch production record did not include all required information.
Conditions, controls -protect; microorganisms, contamination (21 CFR 111.365(a))
You did not perform manufacturing operations under conditions and controls that protect against the potential for contamination.
Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))
You held dietary supplements under conditions that lead to mix-up, contamination, or deterioration.
FEI 1122227
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Westbury, New York
5 citations posted:
- Specifications - components (21 CFR 111.70(b))
- Specifications - finished dietary supplement (21 CFR 111.70(e))
- Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
- Hold - temperature, humidity, light (21 CFR 111.455(a))
See all 5 citations
Specifications - components (21 CFR 111.70(b))
For component(s) used in the manufacture of a dietary supplement, you did not establish necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met.
Specifications - finished dietary supplement (21 CFR 111.70(e))
You did not establish product specifications for identity, purity, strength and composition.
Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.
Hold - temperature, humidity, light (21 CFR 111.455(a))
You did not hold dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.
Product complaint - review, investigation (21 CFR 111.560(c))
Your review and investigation of a product complaint did not extend to all relevant batches and records.
FEI 2431390
No action indicated · No objectionable conditions found
Inspected
Salisbury, Maryland
FEI 1122227
No action indicated · No objectionable conditions found
Inspected
Westbury, New York
FEI 2431390
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Salisbury, Maryland
3 citations posted:
- Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
- Components - contamination, deterioration, mix-ups (21 CFR 111.155(e))
- Batch record - specifications (21 CFR 111.260(i))
Full citation text
Quality control - processes, specifications, written procedures (21 CFR 111.105(a))
Your quality control personnel did not approve or reject deviations or modifications that may affect the identity, purity, strength, or composition of a dietary supplement.
Components - contamination, deterioration, mix-ups (21 CFR 111.155(e))
You did not hold components under conditions that will protect against contamination.
Batch record - specifications (21 CFR 111.260(i))
Your batch production records did not include documentation that the finished dietary supplement meets established specifications.
FEI 1122227
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Westbury, New York
3 citations posted:
- Specifications identity, purity strength, composition (21 CFR 111.70(c)(2))
- Specifications met - verify; finished batch (21 CFR 111.75(c))
- Specifications not met - identity; component, reject (21 CFR 111.77(b))
Full citation text
Specifications identity, purity strength, composition (21 CFR 111.70(c)(2))
You did not provide adequate documentation of your basis for why meeting the in-process specifications, in combination with meeting component specifications, will help ensure that the specifications are met for the identity, purity, strength and composition.
Specifications met - verify; finished batch (21 CFR 111.75(c))
You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength and composition.
Specifications not met - identity; component, reject (21 CFR 111.77(b))
Your quality control personnel did not reject a component that did not meet an identity specification.
FEI 2431390
No action indicated · No objectionable conditions found
Inspected
Salisbury, Maryland
FEI 1122227
No action indicated · No objectionable conditions found
Inspected
Westbury, New York
FEI 2431390
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Salisbury, Maryland
4 citations posted:
- Production, in- process control system - design, quality (21 CFR 111.60(a))
- Exempted, periodic testing; quality control (21 CFR 111.75(d)(2))
- Material review, disposition, follow-up; investigation (21 CFR 111.140 (b)(3)(ii))
- Records - document; results (21 CFR 111.325(b)(2)(ii))
Full citation text
Production, in- process control system - design, quality (21 CFR 111.60(a))
Your production and in-process control system is not designed to ensure that the dietary supplement is manufactured, packaged, labeled, and held in a manner that will ensure the quality of the dietary supplement.
Exempted, periodic testing; quality control (21 CFR 111.75(d)(2))
Your quality control personnel did not review and approve the documentation of why an exempted product specification is met without verification through periodic testing of the finished batch.
Material review, disposition, follow-up; investigation (21 CFR 111.140 (b)(3)(ii))
Your documentation of your material review and disposition decision and follow-up did not include a description of your investigation into the cause of the deviation from the specification or of the unanticipated occurrence.
Records - document; results (21 CFR 111.325(b)(2)(ii))
The documentation for laboratory tests and examinations did not include the results of the testing and examination.
FEI 1122227
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Salisbury, Maryland
FEI 1122227
No action indicated · No objectionable conditions found
Inspected
Salisbury, Maryland
1 citation posted:
- Absence of Written Procedures (21 CFR 211.100(a))
Full citation text
Absence of Written Procedures (21 CFR 211.100(a))
There are no written procedures for production and process controls designed to assure that the drug products have the identity, strength, quality, and purity they purport or are represented to possess.
FEI 1122227
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Salisbury, Maryland
3 citations posted:
- Changes to Procedures Not Reviewed, Approved (21 CFR 211.100(a))
- Complete instructions, procedures, specifications et. al. (21 CFR 211.186(b)(9))
- Written record of investigation incomplete (21 CFR 211.192)
Full citation text
Changes to Procedures Not Reviewed, Approved (21 CFR 211.100(a))
Changes to written procedures are not drafted, reviewed and approved by the appropriate organizational unit and reviewed and approved by the quality control unit.
Complete instructions, procedures, specifications et. al. (21 CFR 211.186(b)(9))
Master production and control records lack specifications.
Written record of investigation incomplete (21 CFR 211.192)
Written records of investigations into unexplained discrepancies do not include the conclusions and follow-up.
FEI 1122227
We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check
What Tishcon Corp. says it offers
From Tishcon Corp.’s own website, checked . Not verified by us.
Products
Herbal & botanicalShow quoteHide quote“Tishcon manufactures the highest quality standardized herbal extracts in softgels.”
“Tishcon manufactures the highest quality standardized herbal extracts in softgels.”
Source page · seen on
Vitamins & mineralsShow quoteHide quote“Tishcon is a leading manufacturer of chewable supplements with proven expertise in chewable multivitamin formulations.”
“Tishcon is a leading manufacturer of chewable supplements with proven expertise in chewable multivitamin formulations.”
Source page · seen on
Services
Custom formulationShow quoteHide quote“From custom formulations to contract manufacturing, Tishcon helps clients put their product vision into the hands of consumers.”
“From custom formulations to contract manufacturing, Tishcon helps clients put their product vision into the hands of consumers.”
Source page · seen on
Contract manufacturingShow quoteHide quote“From custom formulations to contract manufacturing, Tishcon helps clients put their product vision into the hands of consumers.”
“From custom formulations to contract manufacturing, Tishcon helps clients put their product vision into the hands of consumers.”
Source page · seen on
TurnkeyShow quoteHide quote“We can provide a turn-key capability to take your product from concept to market.”
“We can provide a turn-key capability to take your product from concept to market.”
Source page · seen on
Packaging & bottlingShow quoteHide quote“As a leading contract manufacturer for health and nutrition products, we offer a wide range of packaging options for your products.”
“As a leading contract manufacturer for health and nutrition products, we offer a wide range of packaging options for your products.”
Source page · seen on
Product certifications it claims
VeganShow quoteHide quote“All of our vegan formulations are manufactured to strict vegan specifications in our GMP-certified facilities”
“All of our vegan formulations are manufactured to strict vegan specifications in our GMP-certified facilities”
Source page · seen on
Non-GMOShow quoteHide quote“we are able to meet the demand for formulations that are 100% non-GMO.”
“we are able to meet the demand for formulations that are 100% non-GMO.”
Source page · seen on
HalalShow quoteHide quote“Halal Certified - both plants NY & MD”
“Halal Certified - both plants NY & MD”
Source page · seen on
Gluten-freeShow quoteHide quote“Tishcon manufactures gluten-free vitamins and supplements.”
“Tishcon manufactures gluten-free vitamins and supplements.”
Source page · seen on
Organic productsShow quoteHide quote“Tishcon manufactures the highest quality organic products.”
“Tishcon manufactures the highest quality organic products.”
Source page · seen on
We read the company’s public web pages and keep a claim only when its quote appears on the page. A claim is hidden once we haven’t seen it for 120 days. Spotted something wrong? Tell us · How we collect website claims
What we checked, and what we didn’t
Confirmed from NSF’s public listing
Last checked
- NSF/ANSI 455-2 GMP certification
- 10 facility addresses
- Dosage forms in the certified scope
- Operations listed for each facility
Not verified by us
- Minimum order quantity (MOQ): the smallest order they accept
- Lead times and current capacity
- Prices
- Other certifications, like organic, kosher, halal or NSF Certified for Sport
- Whether they’re taking new clients
- Conditions inside the facility. We don’t visit or audit facilities.
- What the company’s own website says it makes and offers, shown above with quotes
Ask about these in your quote request. How we verify
Other capsule manufacturers in the United States
NSF lists 5 capsule facilities, including one in Tempe, AZ
Tempe, AZ, United States21stcenturyvitamins.com
- Capsules
- Gummies
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a capsule facility in Centennial, CO
Centennial, CO, United States5280smc.com
- Capsules
Operations:- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a capsule facility in Garden Grove, CA
Garden Grove, CA, United Statespackaging.com
- Capsules
- Gummies
- Powders
- Softgels
- Tablets
NSF/ANSI 455-2checked Nov 19, 2026Access Business Group, LLC
USDA OrganicNSF lists a capsule facility in Ada, MI
Ada, MI, United Statesamway.com
- Capsules
- Powders
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
- +1 more
NSF/ANSI 455-2checked Nov 19, 2026NSF lists 2 capsule facilities, including one in Chandler, AZ
Gilbert, AZ, United Statesadeptlifesciences.com
- Capsules
- Liquids
- Powders
- Tablets
Operations:- Liquid formulation
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026ADH Health Products, Inc.
USDA OrganicNSF lists a capsule facility in Congers, NY
Congers, NY, United Statesadhhealth.com
- Capsules
- Oils
- Powders
- Tablets
Operations:- Coating
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026